Verano Launches Third Annual Breast Cancer Awareness Month Donation Effort Supporting the Lynn Sage Breast Cancer Foundation

Dispensary-led punch card campaign will span eleven states throughout October for Breast Cancer Awareness Month

CHICAGO, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the launch of the Company’s third annual campaign on October 1st supporting the Lynn Sage Breast Cancer Foundation for Breast Cancer Awareness Month. Throughout the entire month of October, Verano will host a fundraising campaign across the Company’s Zen Leaf and MÜV dispensaries in eleven states, including: Arizona, Arkansas, Connecticut, Florida, Illinois, Massachusetts, Maryland, Michigan, New Jersey, Nevada and West Virginia.

Following the success of previous dispensary-led punch card campaigns that have generated hundreds of thousands of dollars in proceeds, cannabis customers will have the opportunity to enjoy their favorite medical and adult use cannabis products while supporting the fundraising effort. The Company will facilitate a donation to Lynn Sage Breast Cancer Foundation upon each customer’s punch card being completed, and customers will receive exclusive rewards with each purchase. Punch cards will be available beginning Friday, September 29th.

"We are so very appreciative of Verano’s support of the Lynn Sage Breast Cancer Foundation and their efforts to further our mission of eradicating breast cancer by investing in early career practitioners and innovative research,” said Halee Sage, Lynn Sage Breast Cancer Foundation Board Chair.

“As one of the leading organizations in its field, Lynn Sage Breast Cancer Foundation conducts critical research, education and prevention, and we’re thrilled to offer our support for a third year in a row,” said George Archos, Verano Founder and Chief Executive Officer. “We are proud to once again demonstrate the power of the cannabis community as a catalyst for positive change by uniting our team, patients and customers together to continue the fight against breast cancer throughout October and beyond.”

Verano’s partnership with Lynn Sage Breast Cancer Foundation began in October 2021 with the inaugural launch of its dispensary punch card program in support of Breast Cancer Awareness Month. Following the success of the campaign, with over 7,000 dispensary visitors participating, the campaign has further scaled from six to eleven states across the Company’s operational footprint. To learn more about the Lynn Sage Breast Cancer Foundation, visit

About Verano

Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF), one of the U.S. cannabis industry’s leading companies based on historical revenue, geographic scope and brand performance, is a vertically integrated, multi-state operator embracing a mission of saying Yes to plant progress and the bold exploration of cannabis. Verano offers a superior cannabis shopping experience in medical and adult use markets under the Zen Leaf and MÜV dispensary banners and produces a comprehensive suite of high-quality, regulated cannabis products sold under its diverse portfolio of trusted consumer brands including Verano, MÜV, Savvy, BITS, Encore, and Avexia. Verano’s active operations span 13 U.S. states, comprised of 14 production facilities with over 1,000,000 square feet of cultivation capacity. Learn more at

About Lynn Sage Breast Cancer Foundation

The Lynn Sage Breast Cancer Foundation’s mission is to raise funds for research and education to prevent breast cancer and improve outcomes for individuals with breast cancer. Investments are directed locally within the Chicago area but drive impact globally. The Lynn Sage Breast Cancer Foundation is one of the nation’s leading breast cancer research and education charities. Since 1985, this organization has raised over $40 million for breast cancer research & education advancements. Since the beginning, when Lynn’s dear friends and family established a foundation with a vow to cure this devastating disease, until now, they are dedicated to ending breast cancer.


Grace Bondy
Senior Manager, Communications

Julianna Paterra, CFA
Vice President, Investor Relations

Forward Looking Statements

This press release may contain “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “future”, “scheduled”, “estimates”, “forecasts”, “projects” “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. Forward-looking statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking statements herein, including, without limitation, the risk factors described in the Company’s annual report on Form 10-K for the year ended December 31, 2022 and subsequent quarterly reports on Form 10-Q for 2023 filed with the U.S. Securities and Exchange Commission at The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information or forward-looking statements that are contained or referenced herein, except as may be required in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice regarding forward-looking information and statements.